Ginkgo Bioworks Holdings (DNA) Work In Process (2021)
Ginkgo Bioworks Holdings (DNA) reported Work In Process of $50000.0 for Q4 2021, down 69.33% quarter-over-quarter from $163000.0 in Q3 2021.
Ginkgo Bioworks Holdings (DNA) Work In Process (2021) Analysis & Trends
Ginkgo Bioworks Holdings has reported Work In Process for 1 years, with the latest figure at $50000.0 in Q4 2021.
- For the quarter ending Q4 2021, Work In Process changed N/A year-over-year to $50000.0; the trailing twelve-month figure through Dec 2021 stood at $50000.0 (changed N/A YoY), and the FY2021 full-year result was $50000.0, changed N/A from the prior year.
- Work In Process for Q4 2021 stood at $50000.0, down from $163000.0 in the prior quarter.
- The five-year high for Work In Process was $163000.0 in Q3 2021, with the low at $50000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 546.79 Mn | 546.79 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 163,000.00 |